The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Before Wegovy, 190,000 people in the U.S. were claiming GLP-1 drugs ... with 5.1 percent of white patients with obesity on weight loss drugs compared to just 3.7 percent of Hispanic patients with ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

Catalent's revenue for fiscal first quarter ended Sept. 30 was $1.02 billion, marginally below analysts' estimates of $1.06 ...

Related Ozempic, Wegovy might help ease knee arthritis pain Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics But GLP ...

Wegovy — the weight loss version of the drug Ozempic — was approved by the U.S. Food and Drug Administration in 2021. It was ...

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

While these drugs are mainly used to help control type 2 diabetes and boost weight loss, over the last few years ... look at ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other pharma stocks.

Our list of online Wegovy providers includes reputable brands with licensed healthcare providers who can support you on your ...